Delivery Order SPE2DR25D6028-SPE2DR26FATTT
- Not listed
- On January 8, 2026, the Defense Logistics Agency awarded a delivery order valued at $1,166.16 to AmerisourceBergen Drug Corp for the supply of Dextroamphetamine 10 mg tablets (100 count). This competitively awarded, firm fixed-price contract carries no set-aside designation and requires completion by January 9, 2026. The work will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 31, 2025, for the supply of Dextroamphetamine-Amphetamine 5 mg tablets in quantities of 100, with a ceiling value of $2,364.02 and an ultimate completion date of January 2, 2026. This is a firm fixed price delivery order issued under a competitive, non-set-aside procurement. The contract will be performed at AmerisourceBergen's Conshohocken, Pennsylvania location, the company's corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 3, 2025, for the supply of Dextroamphetamine 5mg tablets (100 count) with a ceiling value of $2,659.93. This is a firm fixed price delivery order with an ultimate completion date of November 4, 2025, and will be performed at the contractor's Conshohocken, Pennsylvania location. No set-aside designation was used for this competitive award. This delivery order falls under AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a delivery order valued at $1,952.64 to AmerisourceBergen Drug Corp for Dextroamphetamine 20mg tablets (100 count) on November 26, 2025, with completion targeted for December 24, 2025. This competitive award, made without set-aside provisions, represents a firm fixed-price delivery order for pharmaceutical supply to support federal medical procurement needs. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 7, 2025, for the supply of Dextroamphetamine-Amphetamine 5 mg tablets in quantities of 100 units, with a contract ceiling value of $1,424.16. This is a firm fixed price delivery order with an ultimate completion date of November 10, 2025, and represents a child contract under AmerisourceBergen's larger indefinite delivery contract with DLA. The award was made through open competition with no...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Dextroamphetamine 5mg tablets (100 count) under a firm fixed-price contract with a ceiling value of $3,760.55 and a completion date of September 8, 2025. The award was made on a competitive basis with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 5, 2026, for the supply of Dextroamphetamine-Amphetamine 20 mg tablets in quantities of 100, with a ceiling value of $2,114.40. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under an existing contract vehicle. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of...
- The Defense Logistics Agency awarded a delivery order valued at $1,388.16 to AmerisourceBergen Drug Corp on November 25, 2025, for the supply of Dextroamphetamine-Amphetamine 5 MG tablets (100s). This delivery order, which is non-set-aside and competitively awarded, represents a firm fixed-price transaction with an ultimate completion date of November 26, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This order falls under...
- The Defense Logistics Agency awarded a delivery order valued at $1,057.61 to AmerisourceBergen Drug Corp for the supply of Dextroamphetamine 5 mg/5 mL (473 mL) on November 26, 2025, with an ultimate completion date of November 28, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and will be performed at the contractor's location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a competitive delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Dextroamphetamine-Amphetamine 20 mg tablets in quantities of 100 units, with a contract ceiling value of $3,857.54. This is a firm fixed-price delivery order with an ultimate completion date of September 10, 2025, and represents a child contract under AmerisourceBergen's broader pharmaceutical supply agreements with DLA. The work will be performed at the...
- SPE2DR25D6028Indefinite Delivery Contract
- SPE2DR25D6028-SPE2DR26FATTTDelivery Order
On January 13, 2026, the Defense Logistics Agency awarded a delivery order valued at $1,725.36 to AmerisourceBergen Drug Corp for the supply of Dextroamphetamine 5mg tablets (100 count). This competitive, firm fixed-price delivery order carries an ultimate completion date of January 14, 2026, and will be performed at the awardee's facility in Conshohocken, Pennsylvania. The award was not designated as a set-aside contract. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at up to $999,999,999.00 and extending through December 2026. This comprehensive prime vendor contract enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally, including medications across multiple therapeutic domains, vaccines, and specialized medical commodities. AmerisourceBergen Drug Corp operates as a subsidiary of Cencora, Inc., which also holds a separate $999,999,999.00 IDC with DLA through December 31, 2031. The company's federal contracting demonstrates significant capacity to fulfill critical pharmaceutical supply needs for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 1/12/26 |